Use of the prognostic biomarker suPAR in the emergency department improves risk stratification but has no effect on mortality: a cluster-randomized clinical trial (TRIAGE III)

Martin Schultz, Line Jee Hartmann Rasmussen, Malene H. Andersen, Jakob S. Stefansson, Alexander C. Falkentoft, Morten Alstrup, Andreas Sandø, Sarah L. K. Holle, Jeppe Meyer, Peter B. S. Törnkvist, Thomas Høi-Hansen, Erik Kjøller, Birgitte Nybo Jensen, Morten Lind, Lisbet Ravn, Thomas Kallemose, Theis Lange, Lars Køber, Lars Simon Rasmussen, Jesper Eugen-OlsenKasper Karmark Iversen

Research output: Contribution to journalJournal articleResearchpeer-review

24 Citations (Scopus)
120 Downloads (Pure)
Original languageEnglish
Article number69
JournalScandinavian Journal of Trauma, Resuscitation and Emergency Medicine
Volume26
Number of pages10
ISSN1757-7241
DOIs
Publication statusPublished - 2018

Keywords

  • Prognostic biomarkers
  • Risk stratification
  • Emergency department

Cite this